Intellectual Property Protection for Dominican Republic Manufacturers: CAFTA-DR IP Framework
Intellectual property protection is a fundamental concern for US manufacturers and technology owners establishing operations in the Dominican Republic. The CAFTA-DR agreement includes a comprehensive Chapter 15 on intellectual property rights, establishing minimum protection standards that exceed basic TRIPS (Trade-Related Aspects of Intellectual Property Rights) requirements and align the Dominican Republic’s IP framework more closely with US standards than most developing country markets.
For US companies bringing proprietary manufacturing processes, product formulations, brand assets, and trade secrets to Dominican operations, understanding the CAFTA-DR IP framework — and the practical steps required to enforce those protections — is an essential pre-entry compliance step.
CAFTA-DR Chapter 15: Key IP Protections
| IP Category | Protection Level | DR Registration Body |
|---|---|---|
| Patents | 20-year term, TRIPS+ | ONAPI |
| Trademarks | Renewable 10-year terms | ONAPI |
| Copyrights | Life + 70 years (authors) | ONDA |
| Trade secrets | Civil and criminal enforcement | Courts / enforcement agencies |
| Geographical indications | CAFTA-DR protected | ONAPI / MINPRE |
| Semiconductor layout designs | Protected | ONAPI |
Patent Protection in Dominican Republic Manufacturing
US companies manufacturing patented products or using patented processes in the Dominican Republic should register those patents with ONAPI (Oficina Nacional de Propiedad Industrial). Dominican patent registration requires a Spanish-language application including patent specification and claims, along with evidence of prior registration in other jurisdictions if claiming priority. Patent applications filed within 12 months of a US filing can claim Paris Convention priority, preserving the earlier filing date.
Pharmaceutical patent protection under CAFTA-DR includes data exclusivity provisions — protecting undisclosed test data submitted for regulatory approval from disclosure or reliance by generic competitors for a minimum of 5 years (pharmaceuticals) and 10 years (agricultural chemicals). These provisions are particularly relevant for US pharmaceutical companies establishing DR-based production of proprietary drug products.
Trade Secret Protection Framework
Trade secret protection in Dominican manufacturing operations is primarily achieved through contractual and operational measures, supported by CAFTA-DR Chapter 15 obligations and Dominican law. Best practices include: comprehensive Non-Disclosure Agreements for all employees with access to proprietary information, executed in Spanish under Dominican law; compartmentalized process documentation limiting employee access to only the process steps relevant to their roles; physical and electronic access controls for sensitive production areas and IT systems; supplier NDAs covering any proprietary specifications shared with Dominican input suppliers; and regular trade secret compliance training aligned with CAFTA-DR enforcement standards.
Trademark Registration and Brand Protection
US companies operating in the Dominican Republic should register their trademarks with ONAPI independently of US USPTO registration. The Dominican Republic is not part of the Madrid Protocol’s international registration system, so US trademark registrations do not automatically extend to the DR. Unregistered marks may have some protection under Dominican unfair competition law, but registered marks receive significantly stronger enforcement standing.
Customs IP Enforcement
Dominican Customs (DGA) has authority to seize counterfeit or infringing goods at the border under CAFTA-DR-aligned IP enforcement provisions. US brand owners manufacturing in the DR should record their trademarks and copyrights with DGA to enable ex-officio border seizures of counterfeit goods. CAFTA-DR also strengthens criminal penalties for willful trademark counterfeiting and copyright piracy on a commercial scale.
Frequently Asked Questions
If a US patent is infringed in Dominican Republic, what remedies are available?
Dominican law provides civil remedies for patent infringement including injunctive relief, damages (actual and in some cases enhanced), destruction of infringing goods, and attorney’s fees for egregious infringement. Criminal remedies are available for willful commercial-scale infringement under CAFTA-DR-enhanced provisions. Enforcement through Dominican courts is improving but may require 2-4 years for full resolution. Interim injunctive relief can be obtained more quickly for clear cases of ongoing infringement.
How should a US company protect its manufacturing process secrets when transferring technology to a DR operation?
Technology transfer to a Dominican manufacturing operation should be structured through a formal Technology License Agreement executed under applicable law, combined with employee-level NDAs and need-to-know access restrictions. The license agreement should address: permitted use scope; confidentiality obligations surviving employment termination; prohibited disclosures to third parties; and remedies for breach. Registering the license agreement with ONAPI for patent-linked technology provides additional enforcement standing.
What is ONDA and what does it protect?
ONDA (Oficina Nacional de Derecho de Autor) is the Dominican Republic’s copyright office, responsible for registration and enforcement of copyright in literary, artistic, musical, and software works. Copyright registration with ONDA is not required for protection (copyright arises automatically) but provides evidentiary advantages in enforcement proceedings and facilitates border seizure of infringing copies.
Ready to run the numbers for your operation?
Get a free analysis covering costs, timeline, tax structure, and CAFTA-DR eligibility for your specific product and market.
Explore More: EGS Insights Hub | DR Manufacturing Sectors | Contact Our Team